Send your comments and tips to whitecoat@globe.com
  Awards Beth Israel Deaconess Medical Ctr. Boston Medical Center Boston University Brigham and Women's Hospital Broad Institute Cambridge Health Alliance Caritas St. Elizabeth's Medical Ctr. Children's Hospital Boston Dana-Farber Cancer Institute Grants Harvard University Joslin Diabetes Center Lahey Clinic Mass. General Hospital Mass. Health Law McLean Hospital MIT New England Baptist Hospital Personnel Moves Public Health Research Short White Coat Tufts-New England Medical Center Tufts University UMass Memorial Medical Center University of Massachusetts VA Medical Centers    A Healthy Blog Running A Hospital Nature Network Boston SciBos - Corie Lok's blog Kevin, M.D. Blog, MD Nurse at small Dr. Gwenn Is In Healthy Children blog WBUR's CommonHealth Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram &
Gazette.
Boston Globe Health and Science staff:
Scott Allen Alice Dembner Carey Goldberg Liz Kowalczyk Stephen Smith Colin Nickerson Beth Daley Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor. Short White Coat blogger Ishani Ganguli Short White Coat blogger Jennifer Srygley  Week of:
November 11
Week of:
November 4
Week of:
October 28
Week of:
October 21
Week of:
October 14
Week of:
October 7
|
« Roadblock looms for subsidized insurance plan | Main | BMC nurses protest scheduled today » Friday, May 11, 2007Today's Globe: stem cell funding, genetic data sharing, Oxycontin fine, anemia drugsFor all the hype and hope surrounding stem cell research, most of the companies trying to develop treatments from these powerful cells live in a place Governor Deval Patrick this week called the "valley of death." Children's Hospital Boston is creating a pilot program that will enable families whose children provide DNA for broad medical research to receive individually tailored information on the findings. Purdue Pharma LP and three current and former executives pleaded guilty and agreed to pay $634.5 million to settle criminal and civil claims they misled doctors as to the addictiveness of Oxycontin. Best-selling anemia drugs from Amgen Inc. and Johnson & Johnson should have their use restricted because of dangerous side effects, a US advisory panel said. Posted by Elizabeth Cooney at 06:23 AM
|
